SCHEMBL45106

SCHEMBL45106

O=C(ON1C(=O)CC(S(=O)(=O)O)C1=O)C1CCC(CN2C(=O)C=CC2=O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22635959 1.00
SCHEMBL4620757 1.00
SCHEMBL2810989 0.99
SCHEMBL29406614 0.99
SCHEMBL15940395 0.94
SCHEMBL706497 0.93
SCHEMBL16448969 0.93
SCHEMBL17735697 0.90 ALDH1A1 (0.30)
SCHEMBL18344257 0.89
SCHEMBL1422833 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9320 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727977-A2 CD276 ANTIBODY AND METHODS OF USE THEREOF Ohio State Innovation Foundation (US) 2026-04-22 EP claimed
EP-4441243-B1 ATTACHING NUCLEIC ACIDS TO A PLATINUM ELECTRODE UNIV PARIS SACLAY (FR) 2026-04-08 EP claimed
US-20260092317-A1 TETHERED AMPLIFICATION PRODUCTS IN CELLS AND TISSUES SINGULAR GENOMICS SYSTEMS INC (US) 2026-04-02 US claimed
US-12570755-B2 Anti-CD20 antibody and uses thereof MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2026-03-10 US claimed
EP-4648791-A1 POLYMERIZED HEMOGLOBIN SIZE FRACTIONATED VIA TANGENTIAL FLOW FILTRATION Ohio State Innovation Foundation (US) 2025-11-19 EP claimed
WO-2025226837-A1 ANTI-BACTERIAL METALLOTHIONEIN ANTIBODIES AND USES THEREOF UNIVERSITY OF CONNECTICUT (US) 2025-10-30 WO claimed
US-20250295745-A1 CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES NORTHWESTERN UNIVERSITY 2025-09-25 US claimed
EP-4577256-A2 SCAFFOLD MATERIALS FOR ARTIFICIAL DERMAL LAYER VitroLabs Inc (US) 2025-07-02 EP claimed
WO-2025091021-A1 POLYMERIZED ALBUMIN AND METHODS OF MAKING AND USING THEREOF OHIO STATE INNOVATION FOUNDATION (US) 2025-05-01 WO claimed
WO-2025091017-A1 SYNTHETIC WHOLE BLOOD SUBSTITUTES OHIO STATE INNOVATION FOUNDATION (US) 2025-05-01 WO claimed
WO-1994018342-A1 PREPARATION OF PHOTOPROTEIN CONJUGATES AND METHODS OF USE THEREOF SEALITE SCIENCES, INC. (US) 1994-08-18 WO claimed
WO-1994013327-A1 IMMUNOREACTIVE REAGENTS EMPLOYING DIHYDROFOLATE REDUCTASE THE WELLCOME FOUNDATION LIMITED (GB) 1994-06-23 WO claimed
WO-1994012216-A1 SEQUENTIAL TARGETING OF TUMOR SITES WITH OLIGONUCLEOTIDE CONJUGATES OF ANTIBODY AND COMPLEMENTARY OLIGONUCLEOTIDE CONJUGATES OF CHELATED RADIONUCLIDE THE WELLCOME FOUNDATION LIMITED (GB) 1994-06-09 WO claimed
US-5272077-A Method for preparing a covalent conjugate of an oligonucleotide and an enzyme EASTMAN KODAK COMPANY (US) 1993-12-21 US claimed
US-5162505-A Proteins modified with positively charged carriers and compositions prepared therefrom CENTOCOR (US) 1992-11-10 US claimed
US-5089423-A Quantitative analysis of immunoractive substances immobilized on solid phase CYBERFLUOR INC. (CA) 1992-02-18 US claimed
EP-0417841-A2 An oligonucleotide-enzyme conjugate and a method for its preparation EASTMAN KODAK COMPANY (US) 1991-03-20 EP claimed
EP-0290269-A2 Immunoassay methods and reagents and methods for producing the latter CYBERFLUOR INC. (CA) 1988-11-09 EP claimed
US-4657853-A Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody E. I. DU PONT DE NEMOURS AND COMPANY (US) 1987-04-14 US claimed
EP-0175560-A2 Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody E.I. DU PONT DE NEMOURS AND COMPANY (US) 1986-03-26 EP claimed